TABLE 1.
Clinical characteristics, fasting plasma lipids, and PCSK9 levels of 254 healthy volunteers (mean ± SD)
| All Subjects (min–max) n = 254 | Men (min–max) n = 117 | Women (min–max) n = 137 | |
|---|---|---|---|
| Age (years) | 42 ± 13 (20–77) | 41 ± 13 (20–77) | 43 ± 12 (21–69) |
| BMI (kg/m2) | 24.5 ± 4.3 (16.2–41.6) | 25.6 ± 4.0 (17.6–38.8) | 23.4 ± 4.4 (16.2–41.6) |
| PCSK9 (ng/ml) | 89.5 ± 31.9 (35.3–225.2) | 85.3 ± 26.9 (35.3–172.1) | 93.1 ± 35.4 (47.4–225.2) |
| TC (mmol/L) | 4.86 ± 0.90 (2.83–7.30) | 4.90 ± 0.89 (3.11–7.05) | 4.83 ± 0.91 (2.83–7.30) |
| TG (mmol/L) | 1.17 ± 0.62 (0.34–4.30) | 1.22 ± 0.64 (0.45–4.30) | 1.12 ± 0.59 (0.34–3.86) |
| LDL-C (mmol/L) | 2.84 ± 0.80 (1.17–4.72) | 3.01 ± 0.80 (1.17–4.72) | 2.69 ± 0.78 (1.36–4.59) |
| HDL-C (mmol/L) | 1.50 ± 0.38 (0.80–2.60) | 1.33 ± 0.32 (0.80–2.36) | 1.64 ± 0.36 (0.83–2.60) |
| TC-HDL-C | 3.44 ± 1.02 (1.70–6.79) | 3.85 ± 1.03 (2.00–6.79) | 3.08 ± 0.88 (1.70–6.19) |
| Glucose (mmol/L) | 4.84 ± 0.61 (3.60–6.70) | 4.89 ± 0.63 (3.60–6.70) | 4.79 ± 0.58 (3.60–6.70) |